Skip to content
Back to recalls
Drug FDA Class I Ongoing Mislabeling

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

StuffbyNainax Published Mar 11, 2026

Risk level

Class I

Dangerous or defective — could cause serious health problems or death.

Severity score 75/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact StuffbyNainax or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

Hazards

Undeclared sildenafil · primaryUndeclared tadalafil

Affected products (1)

MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7

4

Code info: All codes; Exp 12/31/2029

Affected areas

Product was distributed to 4 customers in the US.

Timeline

  1. Initiated
    Dec 15, 2025
  2. Published
    Mar 11, 2026
Recall number
D-0397-2026
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.